Blackstone, Warburg Said to Vie for CVC-Backed Sebia Stake
Blackstone, Warburg Pincus, and Nordic Capital are reportedly vying to acquire a stake in the French diagnostics company Sebia, which is currently backed by CVC Capital Partners. The potential deal could value Sebia at around €5 billion, according to people familiar with the matter. Sebia is a prominent player in the diagnostics industry, particularly in the field of electrophoresis-based tests. The company's products are used in the diagnosis and monitoring of various medical conditions, including multiple myeloma and other hematological disorders. The involvement of these prominent private equity firms suggests that Sebia is an attractive investment opportunity in the growing diagnostics market. The acquisition of a stake in Sebia could provide the winning bidder with a significant presence in the European diagnostics landscape and potential for future growth and expansion.
Source: For the complete article, please visit the original source link below.
